Ruxolitinib for Graft Versus Host Disease in Children – Are we in a New Era?
| Asaf Yanir | Rina Zaizov Division of Pediatric Hematology Oncology, Schneider Children's Medical Center of Israel, Petach-Tiqva, Israel
| Asaf Yanir | Rina Zaizov Division of Pediatric Hematology Oncology, Schneider Children's Medical Center of Israel, Petach-Tiqva, Israel
Aharon Gefen | Division of Pediatric Hematology, Oncology and Bone Marrow Transplants, Rambam Medical Center, Haifa | Faculty of Medicine,
Asaf Yanir | BMT, Cell Processing Facillity, Schneider Children's Medical Center of Israel, Petach-Tiqva, Israel
Ronit Elhasid | Pediatric Hematology Oncology, Dana-Dwek Children’s Hospital, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel
Amos Toren | Pediatric Hemato-Oncology Division, Sheba Medical Center, Ramat Gan | Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
Rupert Handgretinger | Dept. of General Pediatrics, Pediatric Hematology Oncology, University Hospital Tuebingen, Germany
Chairs: Gal Goldstein, Israel Amos Toren, Israe
Sari Peretz | Pediatric Hematology Unit and Research Laboratory, Emek Medical Center, Afula | Clinical Laboratory Unit, Emek Medical
Julie Kanter | UAB Adult Sickle Cell Clinic, Division of Hematology Oncology, University of Alabama at Birmingham, USA
Chairs: Carina Levin, Israel Noa Mandel Shorer, Israel
נותנות החסות לאיגוד:
